The group demonstrated that HMGB1 expression correlates with γ-H2AX expression, a key marker of DNA damage in tumor cells after RT, highlighting the interplay between HMGB1 and RT-induced DNA damage in cancer cells. The gene discussed is HMGB1; the disease is cancer.